Overall, our findings suggest that VME and VMA exert anti-obesity effects in HFD-induced obese mice by activating AMPK and suppressing lipid metabolism in adipose tissue and the liver. This evidence concerns the gene PRKAA2 and obesity due to melanocortin 4 receptor deficiency.